
Lenient Pharmaceuticals Private Limited
About Lenient Pharmaceuticals Private Limited
Data last updated:
Lenient Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 05 January 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51101DL2015PTC274986. Its GSTIN is 07AACCL8005H1ZO (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Aakash Srivastava and Ankita Srivastava.
Its last annual general meeting (AGM) was held on 30 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Office No. – 210 F – 17 2nd Floor Harsha Complex Laxmi Nagar Subhash Chawk, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2019, the company reported a revenue of ₹26.12 Lakh, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹7,488 (net margin 0.3%) and EBITDA of ₹7,488 (EBITDA margin 0.3%). Revenue has grown at a compounded annual rate (CAGR) of 56% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Lenient Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressOffice No. – 210 F – 17 2nd Floor Harsha Complex Laxmi Nagar Subhash Chawk, New Delhi, Delhi, India – 110092
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Lenient Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Lenient Pharmaceuticals is support service to organizations. In detail, this covers other support services to organizations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations |
To see the full business activity and turnover split of Lenient Pharmaceuticals Private Limited, buy the company report.
Financials of Lenient Pharmaceuticals Private Limited
FY 2020 filings availableLenient Pharmaceuticals Private Limited reported revenue of ₹26.12 Lakh (up 6% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 56% over three years, including 6% growth in the latest year. EBITDA rose 114% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7,488 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7,488 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.3% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lenient Pharmaceuticals Private Limited, buy the company report.
Board of directors of Lenient Pharmaceuticals Private Limited
Lenient Pharmaceuticals has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aakash Srivastava Also directs: Macligent LLP | Director | 16 Sep 2020 | 6 Years 2 Months | Current |
| Ankita Srivastava Also directs: Macligent LLP | Director | 05 Jan 2015 | 11 Years 10 Months | Current |
| Inderjeet Singh Rawat | Director | 16 Sep 2020 | 6 Years 2 Months | Current |
Auditor
Lenient Pharmaceuticals Private Limited is audited by SONIKA AGGARWAL AND COMPANY for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SONIKA AGGARWAL AND COMPANY | FY 2017 | 510834 |
Shareholding
The shareholding of Lenient Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Lenient Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Lenient Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lenient Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Lenient Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCL8005H1ZO | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Lenient Pharmaceuticals Private Limited, buy the company report.
Recent activity
Lenient Pharmaceuticals Private Limited has 8 board changes on record since 2015: 3 appointments and 5 cessations. The latest: Aakash Srivastava was appointed as Director on 16 Sep 2020.
Frequently asked questions
Lenient Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 05 January 2015 (11+ years old) and is registered under CIN U51101DL2015PTC274986.
Lenient Pharmaceuticals has 3 current directors:
- Aakash Srivastava - Director
- Ankita Srivastava - Director
- Inderjeet Singh Rawat - Director
The latest financial statements of Lenient Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 30 December 2020. Year-wise statements from 2015 are in the company report.
The GSTIN of Lenient Pharmaceuticals is 07AACCL8005H1ZO, registered in Delhi.
The CIN (Corporate Identification Number) of Lenient Pharmaceuticals is U51101DL2015PTC274986. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lenient Pharmaceuticals was incorporated on 05 January 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
Aakash Srivastava was appointed as Director on 16 Sep 2020. Ashish Kumar ceased to be Director on 16 Sep 2020. Inderjeet Singh Rawat was appointed as Director on 16 Sep 2020. Lenient Pharmaceuticals has 8 board changes on record in total.
The registered office of Lenient Pharmaceuticals is at Office No. – 210 F – 17 2nd Floor Harsha Complex Laxmi Nagar Subhash Chawk, New Delhi, Delhi, India – 110092.
Lenient Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Lenient Pharmaceuticals is compliant as of 14 July 2026. The company is actively filing with the Registrar of Companies.

